_id
690dafd5ccc777a4e85d0b31
Ticker
APM
Name
Aptorum Group Ltd Class A
Exchange
NASDAQ
Address
17 Hanover Square, London, United Kingdom, W1S 1BN
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.aptorumgroup.com
Description
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule which is in preclinical trial for the treatment of gram+ve bacterial infections. In addition, it is developing NLS-1, which is in preclinical trial for the treatment of endometriosis; DLS-1+2, which is in preclinical trial to treat NSCLC with mutation; DLS-3, which is in preclinical trial to treat autoimmune disease; CLS-1, a macromolecule, which is in preclinical trial to treat obesity; and CLS-1 and CLS-3. Further, the company offers NativusWell DOI (NLS-2), a dietary supplement for women undergoing menopause; and provides management services. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Last Close
1
Volume
4499
Current Price
1.03
Change
-0.02
Last Updated
2026-01-20T15:31:52.765Z
Image
data:image/webp;base64,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
Ipo Date
2018-12-18T00:00:00.000Z
Market Cap
8388070
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.5
Target Price
80
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
402768
Operating Income
-402766
Interest Expense
46529
Pretax Income
-449295
Net Income
-441780
Eps
-0.06198858505280634
Dividends Per Share
-
Shares Outstanding
6346823
Income Tax Expense
-
EBITDA
-402766
Operating Margin
-
Total Other Income Expense Net
-46529
Cash
2756894
Short Term Investments
-
Receivables
13659
Inventories
-
Total Current Assets
3005740
Property Plant Equipment
-
Total Assets
18104586
Payables
-
Short Term Debt
156692
Long Term Debt
-
Total Liabilities
4335942
Equity
23133612
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
0.31731317530526576
ROE
-1.9096888112414092
ROA
-2.44015521813092
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
6
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
402768
Quarters > 0 > income Statement > operating Income
-402766
Quarters > 0 > income Statement > interest Expense
46529
Quarters > 0 > income Statement > pretax Income
-449295
Quarters > 0 > income Statement > net Income
-441780
Quarters > 0 > income Statement > eps
-0.06198858505280634
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7126796
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-402766
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-46529
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2756894
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
13659
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3005740
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
18104586
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
156692
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4335942
Quarters > 0 > balance Sheet > equity
23133612
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.06198858505280634
Quarters > 0 > ratios > PB
0.31731317530526576
Quarters > 0 > ratios > ROE
-1.9096888112414092
Quarters > 0 > ratios > ROA
-2.44015521813092
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
928000
Quarters > 1 > income Statement > operating Income
-1072000
Quarters > 1 > income Statement > interest Expense
78462
Quarters > 1 > income Statement > pretax Income
-1499000
Quarters > 1 > income Statement > net Income
-1624000
Quarters > 1 > income Statement > eps
-0.2895346764129078
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5609000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1420000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-427000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
874238
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4545
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
959554
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
16130223
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
3340725
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4353162
Quarters > 1 > balance Sheet > equity
21134514
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-1624010
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
449607
Quarters > 1 > cash Flow > cash From Operations
89728
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1425
Quarters > 1 > cash Flow > net Change In Cash
91153
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.2895346764129078
Quarters > 1 > ratios > PB
0.2733571256949651
Quarters > 1 > ratios > ROE
-7.684113294490709
Quarters > 1 > ratios > ROA
-10.06805671564491
Quarters > 1 > ratios > FCF
89728
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
255046
Quarters > 2 > income Statement > gross Profit
-255000
Quarters > 2 > income Statement > operating Expenses
2469000
Quarters > 2 > income Statement > operating Income
-2869000
Quarters > 2 > income Statement > interest Expense
68462
Quarters > 2 > income Statement > pretax Income
-2659000
Quarters > 2 > income Statement > net Income
-2644000
Quarters > 2 > income Statement > eps
-0.4951310861423221
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5340000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2335000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
209619
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
783085
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
322812
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1534096
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
17704765
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
168325
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4527778
Quarters > 2 > balance Sheet > equity
22654961
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-2643796
Quarters > 2 > cash Flow > depreciation
255046
Quarters > 2 > cash Flow > change In Working Capital
-660709
Quarters > 2 > cash Flow > cash From Operations
-1280887
Quarters > 2 > cash Flow > capital Expenditures
3
Quarters > 2 > cash Flow > cash From Investing
58621
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-1222266
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.4951310861423221
Quarters > 2 > ratios > PB
0.24278126102269612
Quarters > 2 > ratios > ROE
-11.670732957783507
Quarters > 2 > ratios > ROA
-14.933832784563931
Quarters > 2 > ratios > FCF
-1280890
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
454606
Quarters > 3 > income Statement > gross Profit
-455000
Quarters > 3 > income Statement > operating Expenses
3535000
Quarters > 3 > income Statement > operating Income
-3990000
Quarters > 3 > income Statement > interest Expense
27667
Quarters > 3 > income Statement > pretax Income
2264000
Quarters > 3 > income Statement > net Income
2662000
Quarters > 3 > income Statement > eps
0.5137012736395214
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5182000
Quarters > 3 > income Statement > income Tax Expense
-399000
Quarters > 3 > income Statement > EBITDA
2741000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
6254000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2005351
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
70945
Quarters > 3 > balance Sheet > inventories
-118362
Quarters > 3 > balance Sheet > total Current Assets
2476092
Quarters > 3 > balance Sheet > property Plant Equipment
1845983
Quarters > 3 > balance Sheet > total Assets
20640091
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
329644
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5256738
Quarters > 3 > balance Sheet > equity
24846236
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
2662457
Quarters > 3 > cash Flow > depreciation
454606
Quarters > 3 > cash Flow > change In Working Capital
912472
Quarters > 3 > cash Flow > cash From Operations
-1537208
Quarters > 3 > cash Flow > capital Expenditures
42
Quarters > 3 > cash Flow > cash From Investing
65986
Quarters > 3 > cash Flow > cash From Financing
3005932
Quarters > 3 > cash Flow > net Change In Cash
1534710
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.5137012736395214
Quarters > 3 > ratios > PB
0.21481966121548554
Quarters > 3 > ratios > ROE
10.713896463029652
Quarters > 3 > ratios > ROA
12.897229958918302
Quarters > 3 > ratios > FCF
-1537250
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
74
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
255046
Annuals > 0 > income Statement > gross Profit
-255000
Annuals > 0 > income Statement > operating Expenses
3541000
Annuals > 0 > income Statement > operating Income
-3796000
Annuals > 0 > income Statement > interest Expense
146924
Annuals > 0 > income Statement > pretax Income
-4158000
Annuals > 0 > income Statement > net Income
-4268000
Annuals > 0 > income Statement > eps
-0.7826884283880433
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5453000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-3756000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-361000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
874238
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4545
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
959554
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
16130223
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
3340725
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4353162
Annuals > 0 > balance Sheet > equity
21134514
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-4267806
Annuals > 0 > cash Flow > depreciation
255046
Annuals > 0 > cash Flow > change In Working Capital
-211102
Annuals > 0 > cash Flow > cash From Operations
-1191159
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
58621
Annuals > 0 > cash Flow > cash From Financing
1425
Annuals > 0 > cash Flow > net Change In Cash
-1131113
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.7826884283880433
Annuals > 0 > ratios > PB
0.2657543958664013
Annuals > 0 > ratios > ROE
-20.194455382319177
Annuals > 0 > ratios > ROA
-26.459646590130838
Annuals > 0 > ratios > FCF
-1191159
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
431378
Annuals > 1 > income Statement > cost Of Revenue
420812
Annuals > 1 > income Statement > gross Profit
10566
Annuals > 1 > income Statement > operating Expenses
10612000
Annuals > 1 > income Statement > operating Income
-10601000
Annuals > 1 > income Statement > interest Expense
121145
Annuals > 1 > income Statement > pretax Income
-4341000
Annuals > 1 > income Statement > net Income
-2825000
Annuals > 1 > income Statement > eps
-0.6248617562486176
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4521000
Annuals > 1 > income Statement > income Tax Expense
-1516332
Annuals > 1 > income Statement > EBITDA
-9476236
Annuals > 1 > income Statement > operating Margin
-2457.473491925875
Annuals > 1 > income Statement > total Other Income Expense Net
6260000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2005351
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
70945
Annuals > 1 > balance Sheet > inventories
-118362
Annuals > 1 > balance Sheet > total Current Assets
2476092
Annuals > 1 > balance Sheet > property Plant Equipment
1845983
Annuals > 1 > balance Sheet > total Assets
20640091
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
329644
Annuals > 1 > balance Sheet > long Term Debt
3058500
Annuals > 1 > balance Sheet > total Liabilities
5256738
Annuals > 1 > balance Sheet > equity
24846236
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4340975
Annuals > 1 > cash Flow > depreciation
1125254
Annuals > 1 > cash Flow > change In Working Capital
407066
Annuals > 1 > cash Flow > cash From Operations
-7724364
Annuals > 1 > cash Flow > capital Expenditures
3010
Annuals > 1 > cash Flow > cash From Investing
624767
Annuals > 1 > cash Flow > cash From Financing
4092068
Annuals > 1 > cash Flow > net Change In Cash
-3007529
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.6248617562486176
Annuals > 1 > ratios > PB
0.1874179251939811
Annuals > 1 > ratios > ROE
-11.369931445551753
Annuals > 1 > ratios > ROA
-13.686955159257778
Annuals > 1 > ratios > FCF
-7727374
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-17.913231550983127
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1296000
Annuals > 2 > income Statement > cost Of Revenue
1216000
Annuals > 2 > income Statement > gross Profit
80065
Annuals > 2 > income Statement > operating Expenses
17254000
Annuals > 2 > income Statement > operating Income
-17509113
Annuals > 2 > income Statement > interest Expense
146588
Annuals > 2 > income Statement > pretax Income
-11525000
Annuals > 2 > income Statement > net Income
-9800000
Annuals > 2 > income Statement > eps
-2.7458671896889886
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3569000
Annuals > 2 > income Statement > income Tax Expense
-6211000
Annuals > 2 > income Statement > EBITDA
-10317595
Annuals > 2 > income Statement > operating Margin
-1351.0118055555556
Annuals > 2 > income Statement > total Other Income Expense Net
5984011
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1882545
Annuals > 2 > balance Sheet > short Term Investments
102481
Annuals > 2 > balance Sheet > receivables
1180711
Annuals > 2 > balance Sheet > inventories
27722
Annuals > 2 > balance Sheet > total Current Assets
7067802
Annuals > 2 > balance Sheet > property Plant Equipment
3174603
Annuals > 2 > balance Sheet > total Assets
20867371
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
6323782
Annuals > 2 > balance Sheet > long Term Debt
500000
Annuals > 2 > balance Sheet > total Liabilities
13034066
Annuals > 2 > balance Sheet > equity
15712094
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11525102
Annuals > 2 > cash Flow > depreciation
1207510
Annuals > 2 > cash Flow > change In Working Capital
1397913
Annuals > 2 > cash Flow > cash From Operations
-12318965
Annuals > 2 > cash Flow > capital Expenditures
186916
Annuals > 2 > cash Flow > cash From Investing
2444896
Annuals > 2 > cash Flow > cash From Financing
6625462
Annuals > 2 > cash Flow > net Change In Cash
-3248607
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.7458671896889886
Annuals > 2 > ratios > PB
0.23396435891995046
Annuals > 2 > ratios > ROE
-62.37233560338934
Annuals > 2 > ratios > ROA
-46.963271032081614
Annuals > 2 > ratios > FCF
-12505881
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-9.649599537037037
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1542000
Annuals > 3 > income Statement > cost Of Revenue
1460000
Annuals > 3 > income Statement > gross Profit
81854
Annuals > 3 > income Statement > operating Expenses
19289000
Annuals > 3 > income Statement > operating Income
-19207000
Annuals > 3 > income Statement > interest Expense
93601
Annuals > 3 > income Statement > pretax Income
-27114000
Annuals > 3 > income Statement > net Income
-25048000
Annuals > 3 > income Statement > eps
-7.150442477876106
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3503000
Annuals > 3 > income Statement > income Tax Expense
-1826000
Annuals > 3 > income Statement > EBITDA
-25828117
Annuals > 3 > income Statement > operating Margin
-1245.5901426718547
Annuals > 3 > income Statement > total Other Income Expense Net
-7907000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
8131217
Annuals > 3 > balance Sheet > short Term Investments
236615
Annuals > 3 > balance Sheet > receivables
3560945
Annuals > 3 > balance Sheet > inventories
35775
Annuals > 3 > balance Sheet > total Current Assets
12688300
Annuals > 3 > balance Sheet > property Plant Equipment
4032605
Annuals > 3 > balance Sheet > total Assets
21907243
Annuals > 3 > balance Sheet > payables
4172565
Annuals > 3 > balance Sheet > short Term Debt
398017
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4401121
Annuals > 3 > balance Sheet > equity
23607345
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-27114293
Annuals > 3 > cash Flow > depreciation
1192578
Annuals > 3 > cash Flow > change In Working Capital
1018288
Annuals > 3 > cash Flow > cash From Operations
-14651633
Annuals > 3 > cash Flow > capital Expenditures
137776
Annuals > 3 > cash Flow > cash From Investing
16507039
Annuals > 3 > cash Flow > cash From Financing
2780725
Annuals > 3 > cash Flow > net Change In Cash
4636131
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-7.150442477876106
Annuals > 3 > ratios > PB
0.15283760202597962
Annuals > 3 > ratios > ROE
-106.10257104303767
Annuals > 3 > ratios > ROA
-114.33661460732417
Annuals > 3 > ratios > FCF
-14789409
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-9.591056420233462
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.06198858505280634
Valuation > metrics > PB
0.31731317530526576
Valuation > final Score
70
Valuation > verdict
68.3% Undervalued
Profitability > metrics > ROE
-1.9096888112414092
Profitability > metrics > ROA
-14.697878059978574
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.18743039348978446
Risk > metrics > Interest Coverage
-8.656235895892884
Risk > final Score
25
Risk > verdict
High
Liquidity > metrics > Current Ratio
19.182472621448447
Liquidity > metrics > Quick Ratio
19.182472621448447
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
66
Prev Risks > 0
5
Prev Risks > 1
-108
Prev Risks > 2
-517
Prev Liquidities > 0
24
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:24:02.284Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-28
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-18
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.06
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.29
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.29
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-12-20
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.5
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.5
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-03-31
Earnings History > 4 > report Date
2023-04-28
Earnings History > 4 > date
2023-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-2.22
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-09-30
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.05
Earnings History > 5 > eps Estimate
-3
Earnings History > 5 > eps Difference
2.95
Earnings History > 5 > surprise Percent
98.3333
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-04-29
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.25
Earnings History > 6 > eps Estimate
-3.3
Earnings History > 6 > eps Difference
3.05
Earnings History > 6 > surprise Percent
92.4242
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-09-15
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.47
Earnings History > 7 > eps Estimate
-3
Earnings History > 7 > eps Difference
2.53
Earnings History > 7 > surprise Percent
84.3333
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-04-19
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.38
Earnings History > 8 > eps Estimate
-3.1
Earnings History > 8 > eps Difference
3.48
Earnings History > 8 > surprise Percent
112.2581
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2021-03-31
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2346
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.2346
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-09-30
Earnings History > 10 > report Date
2020-12-31
Earnings History > 10 > date
2020-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.1889
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.1889
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-09-01
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.21
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.21
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-03-31
Earnings History > 12 > report Date
2020-04-29
Earnings History > 12 > date
2020-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.33
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.33
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-12-31
Earnings History > 13 > report Date
2020-03-31
Earnings History > 13 > date
2019-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.1036
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.1036
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-09-30
Earnings History > 14 > report Date
2019-12-31
Earnings History > 14 > date
2019-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.1653
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.1653
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-06-30
Earnings History > 15 > report Date
2019-09-09
Earnings History > 15 > date
2019-06-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.31
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.31
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-03-31
Earnings History > 16 > report Date
2019-04-15
Earnings History > 16 > date
2019-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.53
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.53
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2018-12-31
Earnings History > 17 > report Date
2019-03-31
Earnings History > 17 > date
2018-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.1568
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.1568
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2018-09-30
Earnings History > 18 > report Date
2018-12-04
Earnings History > 18 > date
2018-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.41
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.41
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2018-06-30
Earnings History > 19 > report Date
2018-09-30
Earnings History > 19 > date
2018-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.1671
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.1671
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2018-03-31
Earnings History > 20 > report Date
2018-06-30
Earnings History > 20 > date
2018-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0985
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0985
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2017-12-31
Earnings History > 21 > report Date
2018-03-31
Earnings History > 21 > date
2017-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0985
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0985
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2017-09-30
Earnings History > 22 > report Date
2017-12-31
Earnings History > 22 > date
2017-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0269
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0269
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-06-30
Earnings History > 23 > report Date
2017-09-30
Earnings History > 23 > date
2017-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0269
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0269
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2017-03-31
Earnings History > 24 > report Date
2017-06-30
Earnings History > 24 > date
2017-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.02
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.02
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2016-12-31
Earnings History > 25 > report Date
2017-03-31
Earnings History > 25 > date
2016-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.02
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.02
Earnings History > 25 > surprise Percent
-
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; and RPIDD, a liquid biopsy rapid pathogen diagnostic which is in preclinical trial to treat pathogen molecular diagnostics. The company also develops SACT-COV19, a repurposed small molecule which is in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule which is in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule which is in preclinical trial for the treatment of gram+ve bacterial infections. In addition, it is developing NLS-1, which is in preclinical trial for the treatment of endometriosis; DLS-1+2, which is in preclinical trial to treat NSCLC with mutation; DLS-3, which is in preclinical trial to treat autoimmune disease; CLS-1, a macromolecule, which is in preclinical trial to treat obesity; and CLS-1 and CLS-3. Further, the company offers NativusWell DOI (NLS-2), a dietary supplement for women undergoing menopause; and provides management services. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/Aad pepper media International (ETR:APM) Stock Price Down 0.7% - Here's Why MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$80
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 1.46% of the total shares of Aptorum Group Ltd Class A
1.
Fidelity Nasdaq Composite ETF(0.8439%)
since
2025/08/29
2.
Geode Capital Management, LLC(0.5242%)
since
2025/06/30
3.
Advisor Group Holdings, Inc.(0.077%)
since
2025/06/30
4.
Citigroup Inc(0.0139%)
since
2025/06/30
5.
SBI Securities Co Ltd(0.0001%)
since
2025/06/30
6.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
7.
Susquehanna International Group, LLP(0%)
since
2025/06/30
8.
XTX Topco Ltd(0%)
since
2025/06/30
9.
UBS Group AG(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.06
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.